Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

ESPR

Esperion Therapeutics (ESPR)

Esperion Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ESPR
DateTimeSourceHeadlineSymbolCompany
08/03/20219:27AMEdgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ESPREsperion Therapeutics Inc
08/03/20218:57AMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ESPREsperion Therapeutics Inc
08/03/20217:00AMGlobeNewswire Inc.ESPERION Reports Second Quarter 2021 Financial Results and Provides Company UpdateNASDAQ:ESPREsperion Therapeutics Inc
07/27/20218:00AMGlobeNewswire Inc.Esperion to Participate in Upcoming Virtual Investor ConferenceNASDAQ:ESPREsperion Therapeutics Inc
07/13/20218:00AMGlobeNewswire Inc.Esperion to Report Second Quarter 2021 Financial Results August 3, 2021NASDAQ:ESPREsperion Therapeutics Inc
07/08/20217:30AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
07/08/20217:26AMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ESPREsperion Therapeutics Inc
07/01/20215:00PMGlobeNewswire Inc.Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:ESPREsperion Therapeutics Inc
06/30/20214:27PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
06/28/20214:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
06/28/20217:59AMGlobeNewswire Inc.ESPERION Appoints JoAnne Micale Foody, MD, FACC, FAHA as Chief Medical OfficerNASDAQ:ESPREsperion Therapeutics Inc
05/28/20215:02PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ESPREsperion Therapeutics Inc
05/28/20214:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
05/28/20214:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
05/28/20214:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
05/28/20214:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
05/28/20214:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
05/28/20214:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
05/28/20214:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
05/28/20214:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
05/26/202111:53AMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
05/24/20218:00AMGlobeNewswire Inc.Esperion to Participate in Two Upcoming Virtual Investor ConferencesNASDAQ:ESPREsperion Therapeutics Inc
05/21/20212:07PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
05/18/20215:06PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
05/17/20219:09AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ESPREsperion Therapeutics Inc
05/17/20219:01AMGlobeNewswire Inc.ESPERION Appoints Sheldon Koenig as President and CEONASDAQ:ESPREsperion Therapeutics Inc
05/15/202112:00PMGlobeNewswire Inc.Simulation Model based on Pooled Phase 3 Data Demonstrating NEXLETOL® (bempedoic acid) Tablet’s Potential to Lower Absolut...NASDAQ:ESPREsperion Therapeutics Inc
05/07/20213:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ESPREsperion Therapeutics Inc
05/06/20218:00AMGlobeNewswire Inc.Esperion to Participate in Two Upcoming Virtual Investor ConferencesNASDAQ:ESPREsperion Therapeutics Inc
05/04/20215:22PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ESPREsperion Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:ESPR